Fanchin R et al
GHK-Cu is an endogenous occurring copper-binding tripeptide composed of glycine (G), histidine (H), and lysine (K)
Presence of information or adjustment controlling for menstrual cycle phase, symptoms and treatments is highlighted, and the results are further summarized by biological compartment
The "gradual decline" group (approximately 40-50% of users) represents modal experience where benefits slowly regress toward pre-treatment baseline over 4-8 months, typically affecting users who completed shorter treatment courses (2-4 months), used lower concentrations or inconsistent application, possessed moderate to severe baseline skin damage requiring ongoing support, maintained adequate but not optimal complementary skincare, experienced significant lifestyle stressors affecting skin health including poor sleep or high stress, and faced genetic or age-related collagen production limitations
Available from: Devinsky O, et al
Osteoclasts engulf the drug after it binds hydroxyapatite, and the cell undergoes apoptosis